Alzheimer’s Disease (AD) is a worldwide problem that does not yet have a clear solution. Although new treatments are starting to emerge, they do not work for every patient. The reason is likely individual difference in the specific, molecular, causes of AD. In our project, we will explore an innovative method to classify AD patients and guide personalized treatment selection and treatment development. We hope this custom approach allows successfully treating more AD cases.